Phoxilium 1.2 mmol/l phosphate Solution for haemodialysis/haemofiltration أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

phoxilium 1.2 mmol/l phosphate solution for haemodialysis/haemofiltration

gambro lundia ab - calcium chloride dihydrate; magnesium chloride hexahydrate; sodium chloride ph.eur.; sodium hydrogen carbonate; potassium chloride; disodium phosphate dihydrate - solution for haemodialysis/haemofiltration - 1.2 mmol/l - hemofiltrates

TETAVAX, suspension for injection in multidose presentation, adsorbed tetanus vaccine مالطا - الإنجليزية - Medicines Authority

tetavax, suspension for injection in multidose presentation, adsorbed tetanus vaccine

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - tetanus toxoid - suspension for injection - tetanus toxoid 40 iu - vaccines

Lutrate 1 month Depot 3.75 mg powder and solvent for prolonged-release suspension for injection المملكة المتحدة - الإنجليزية - myHealthbox

lutrate 1 month depot 3.75 mg powder and solvent for prolonged-release suspension for injection

mercury pharmaceuticals limited - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 3.75 mg - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - lutrate 1 month depot is indicated for palliative treatment of locally advanced or metastatic prostate cancer.

Lutrate 3 month Depot 22.5 mg powder and solvent for prolonged-release suspension for injection المملكة المتحدة - الإنجليزية - myHealthbox

lutrate 3 month depot 22.5 mg powder and solvent for prolonged-release suspension for injection

mercury pharmaceuticals limited - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection. - 22.5 mg - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - lutrate 3 month depot is indicated for palliative treatment of hormone dependent advanced prostate cancer.

Electromechanical lithotripsy system, extracorporeal أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

electromechanical lithotripsy system, extracorporeal

lithostar pty ltd atf the mansell family trust - 18415 - electromechanical lithotripsy system, extracorporeal - the intended purpose of this device is to send non - invasive shock waves from outside the body in order to fragment or pulverize stones that have developed within the body allowing them to pass from the body as sand sized fragments during natural excretion